Molecular Medicine Reports · 2018 · 60 citations · 25 references
MedicineOncologyPharmacologyBreast OncologyCancer PharmacologyMolecular OncologyCancer Cell SignalingOncogenic Signaling PathwaysSignal Transduction In CancerCancer Cell Proliferation InhibitionCancer Signaling PathwaysCell Cycle DynamicsCell Cycle InhibitionG1 Phase ControlMicrorna In CancerMicrorna In Cell ProliferationMicrorna Regulation In Cancer
Rapid proliferation is one of the critical characteristics of breast cancer. However, the underlying regulatory mechanism of breast cancer cell proliferation is largely unclear. The present study indicated that sevoflurane, one of inhalational anesthetics, could significantly suppress breast cancer cell proliferation by arresting cell cycle at G1 phase. Notably, the rescue experiment indicated that miR-203 was upregulated by sevoflurane and mediated the function of sevoflurane on suppressing the breast cancer cell proliferation. The present study indicated the function of the sevoflurane/miR-203 signaling pathway on regulating breast cancer cell proliferation. These results provide mechanistic insight into how the sevoflurane/miR-203 signaling pathway supresses proliferation of breast cancer cells, suggesting the sevoflurane/miR-203 pathway may be a potential target in the treatment of breast cancer.
25
MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells
Na Xu, Thales Papagiannakopoulos, Guangjin Pan et al. · Cell · 2009 · 1.1K citations · Full text
MicroRNA Regulation of Cell Lineages in Mouse and Human Embryonic Stem Cells
Kathryn N. Ivey, Alecia N. Muth, Joshua Arnold et al. · Cell stem cell · 2008 · 604 citations · Full text
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
Alexandros Laios, Sharon O’Toole, Richard Flavin et al. · Molecular Cancer · 2008 · 301 citations · Full text
Medicine, Cancer Biology, Oncology +17